relatlimab,nivolumab
bms
['melanoma', 'melsm', 'nivolumab', 'nivo', 'relatlimab']
nivolumab plus relatlimab demonstrates sustained pfs benefit in advanced melanoma #asco22 #melsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.